Clearside Biomedical reports Q2 EPS (10c), consensus (13c)
PremiumThe FlyClearside Biomedical reports Q2 EPS (10c), consensus (13c)
1M ago
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
Options Volatility and Implied Earnings Moves Today, August 12, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 12, 2024
1M ago
Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET
PremiumPress ReleasesClearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET
2M ago
Clearside Biomedical appoints Yiu to its Scientific Advisory Board
Premium
The Fly
Clearside Biomedical appoints Yiu to its Scientific Advisory Board
2M ago
Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board
Premium
Press Releases
Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board
2M ago
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
PremiumPress ReleasesClearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
3M ago
Clearside Biomedical announces oral presentations at CTS meeting
Premium
The Fly
Clearside Biomedical announces oral presentations at CTS meeting
3M ago
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
Premium
Press Releases
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100